2009 |
 |
|
| |
|
 |
Codex™ Panels agreement with Roche |
| |
|
|
Further expanded Shell biofuels collaboration |
| |
|
|
Licensing agreement with Teva |
2008 |
 |
|
|
| |
|
|
Expanded collaboration with Arch Pharmalabs, India |
| |
|
|
Codexis Laboratories Hungary opened |
2007 |
|
|
|
| |
|
|
Extended Shell biofuels collaboration to broad, 5 year program |
| |
|
|
Codexis Laboratories Singapore opened |
| |
|
|
Acquisition of BioCatalytics |
| |
|
|
Collaboration signed with Merck |
| |
|
|
Important research results published in Nature Biotechnology |
| |
|
|
Codex™ Biocatalyst Panels Introduced |
2006 |
|
|
|
| |
|
|
Shell collaboration in biofuels |
| |
|
|
Direct sale of generic pharmaceutical intermediates begun |
| |
|
|
Collaboration signed with Schering-Plough |
| |
|
|
U.S. EPA's Presidential Green Chemistry Challenge Award |
2005 |
|
|
|
| |
|
|
Collaborations signed with Bristol-Myers Squibb, Arch |
| |
|
|
European expansion with acquisition of Jülich Fine Chemicals, Germany |
2004 |
|
|
|
| |
|
|
Collaborations signed with Pfizer, Teva, Lonza |
2003 |
|
|
|
| |
|
|
Collaborations signed with Sandoz, Cargill |
2002 |
|
|
|
| |
 |
Codexis incorporated, launches operations |
